AMGEN ANNOUNCES WEBCAST OF 2022 SECOND QUARTER FINANCIAL RESULTS
Amgen will report its second quarter financial results on August 4, 2022, after U.S. market close. A conference call with senior management, including CEO Robert A. Bradway, is scheduled for 2:00 p.m. PT. The call will be accessible via live audio broadcast online and will be archived for at least 90 days. Amgen, a leader in biotechnology since 1980, is focused on serious illnesses and is part of the Dow Jones Industrial Average and Nasdaq-100. The company is recognized for its significant contributions to health and was named one of the 25 World's Best Workplaces™.
- Scheduled conference call for Q2 results indicates transparency.
- Amgen is recognized as a leading biotechnology company.
- Company's commitment to innovative therapeutics aligns with improving health outcomes.
- None.
THOUSAND OAKS, Calif., Aug. 1, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Thursday, August 4, 2022, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 2:00 p.m. PT. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.
Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2021, Amgen was named one of the 25 World's Best Workplaces™ by Fortune and Great Place to Work™ and one of the 100 most sustainable companies in the world by Barron's.
For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.
CONTACT: Amgen, Thousand Oaks
Jessica Akopyan, 805-447-0974 (media)
Megan Fox, 805-447-1423 (media)
Arvind Sood, 805-447-1060 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2022-second-quarter-financial-results-301597095.html
SOURCE Amgen
FAQ
When will Amgen report its second quarter financial results for 2022?
Who will participate in the Amgen Q2 financial results conference call?
How can I access the Amgen Q2 financial results conference call?
What recognition has Amgen received for its workplace environment?
